Integrated molecular and multiparametric MRI mapping of high-grade glioma identifies regional biologic signatures
Leland S. Hu,Fulvio D’Angelo,Taylor M. Weiskittel,Francesca P. Caruso,Shannon P. Fortin Ensign,Mylan R. Blomquist,Matthew J. Flick,Lujia Wang,Christopher P. Sereduk,Kevin Meng-Lin,Gustavo De Leon,Ashley Nespodzany,Javier C. Urcuyo,Ashlyn C Gonzales,Lee Curtin,Erika M. Lewis,Kyle W. Singleton,Timothy Dondlinger,Aliya Anil,Natenael B. Semmineh,Teresa Noviello,Reyna A. Patel,Panwen Wang,Junwen Wang,Jennifer M. Eschbacher,Andrea Hawkins-Daarud,Pamela R. Jackson,Itamar S. Grunfeld,Christian Elrod,Gina L. Mazza,Sam C. McGee,Lisa Paulson,Kamala Clark-Swanson,Yvette Lassiter-Morris,Kris A. Smith,Peter Nakaji,Bernard R. Bendok,Richard S. Zimmerman,Chandan Krishna,Devi P. Patra,Naresh P. Patel,Mark Lyons,Matthew Neal,Kliment Donev,Maciej M. Mrugala,Alyx B. Porter,Scott C. Beeman,Todd R. Jensen,Kathleen M. Schmainda,Yuxiang Zhou,Leslie C. Baxter,Christopher L. Plaisier,Jing Li,Hu Li,Anna Lasorella,C. Chad Quarles,Kristin R. Swanson,Michele Ceccarelli,Antonio Iavarone,Nhan L. Tran
DOI: https://doi.org/10.1038/s41467-023-41559-1
IF: 16.6
2023-09-28
Nature Communications
Abstract:Abstract Sampling restrictions have hindered the comprehensive study of invasive non-enhancing (NE) high-grade glioma (HGG) cell populations driving tumor progression. Here, we present an integrated multi-omic analysis of spatially matched molecular and multi-parametric magnetic resonance imaging (MRI) profiling across 313 multi-regional tumor biopsies, including 111 from the NE, across 68 HGG patients. Whole exome and RNA sequencing uncover unique genomic alterations to unresectable invasive NE tumor, including subclonal events, which inform genomic models predictive of geographic evolution. Infiltrative NE tumor is alternatively enriched with tumor cells exhibiting neuronal or glycolytic/plurimetabolic cellular states, two principal transcriptomic pathway-based glioma subtypes, which respectively demonstrate abundant private mutations or enrichment in immune cell signatures. These NE phenotypes are non-invasively identified through normalized K2 imaging signatures, which discern cell size heterogeneity on dynamic susceptibility contrast (DSC)-MRI. NE tumor populations predicted to display increased cellular proliferation by mean diffusivity (MD) MRI metrics are uniquely associated with EGFR amplification and CDKN2A homozygous deletion. The biophysical mapping of infiltrative HGG potentially enables the clinical recognition of tumor subpopulations with aggressive molecular signatures driving tumor progression, thereby informing precision medicine targeting.
multidisciplinary sciences